Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) is seeking applicants for the Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access. The CIDR provides genomic services, including high-throughput genotyping and sequencing, and statistical genetics services to aid in the identification of genes or genetic modifications that contribute to human health and disease. The services provided by the CIDR are designed to support research in the field of human genetics and genomics. Some key points about this opportunity include: • The CIDR provides the most up-to-date platforms, services, and statistical genetic support. • The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. • The opportunity is open to a variety of eligible applicants, including nonprofits, small businesses, and institutions of higher education. • The estimated application response date is Sep 03, 2026, and the estimated award date is Dec 04, 2026.